Skip to content
GenoLensGenoLens

AMH

Chr 19p13.3

anti-Mullerian hormone

Aliases:
MIF, MIS
MANE:
ENST00000221496.5

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Differences in sex development

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • persistent Mullerian duct syndrome

    0.79
  • Persistent Müllerian duct syndrome

    0.72
  • genetic non-acquired premature ovarian failure

    0.26
  • hereditary disease

    0.19
  • polycystic ovary syndrome

    0.13
  • obesity disorder

    0.13
  • endometriosis

    0.12
  • cancer

    0.11
  • Obesity

    0.11
  • obesity due to melanocortin 4 receptor deficiency

    0.11

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Anti-Muellerian hormone

The anti-Muellerian hormone (AMH) plays an important role in several reproductive functions (PubMed:14742691, PubMed:34155118, PubMed:3754790, PubMed:8469238). Anti-Muellerian hormone binds and activates AMHR2, its specific type-II receptor, that heterodimerizes with type-I receptors (ACVR1 and BMPR1A) to regulate target gene expression through downstream SMAD protein signal transduction (PubMed:20861221, PubMed:34155118). Produced and secreted by Sertoli cells of the male fetus, anti-Muellerian hormone induces Muellerian duct regression during male fetal sexual differentiation (PubMed:34155118, PubMed:3754790, PubMed:8469238). In female, it is produced by granulosa cells of the preantral and small antral follicles and acts as a negative regulator of the primordial to primary follicle transition and decreases FSH sensitivity of growing follicles (PubMed:14742691). Also plays a role in Leydig cell differentiation and function (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.